COVID-19 - deliberating beyond steroids in 2021.

Mahendran, Arul J; Gupta, Neeraj Kumar; Gupta, Nitesh; Kumar, Rohit; Ish, Pranav

Mahendran, Arul J; Gupta, Neeraj Kumar; Gupta, Nitesh; Kumar, Rohit; Ish, Pranav.

Mahendran AJ; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Gupta NK; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Gupta N; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Kumar R; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Ish P; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India. pranavish2512@gmail.com.

Adv Respir Med ; 89(6): 612-614, 2021.

Article in English | MEDLINE | ID: covidwho-1595644

Subject(s)

Antibodies, Monoclonal, Humanized; COVID-19 Drug Treatment; Immunosuppressive Agents; Antibodies, Monoclonal, Humanized/adverse effects; Antibodies, Monoclonal, Humanized/therapeutic use; Humans; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; India; Steroids

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment / Immunosuppressive Agents Limits: Humans Country/Region as subject: Asia Language: English Journal: Adv Respir Med Year: 2021 Document Type: Article Affiliation country: ARM.a2021.0114

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google